Incidence in the U.S. active-duty military population and the SEER program for breast, lung, prostate, colorectal, testicular, and cervical cancers by race and gender; ages 20 to 59 years; comparison of 2000-2004 to 1990-1994
Cancer site . | 1990-1994 . | . | 2000-2004 . | . | IRR* (95% CI†) . |
---|---|---|---|---|---|
. | Count . | Rate† (95% CI) . | Count . | Rate† (95% CI) . | . |
Colorectum | |||||
White males | |||||
ACTUR | 171 | 3.08 (2.63-3.57) | 182 | 4.09 (3.51-4.74) | 1.33 (1.07-1.65) |
SEER | 5,099 | 3.84 (3.64-4.05) | 6,802 | 4.74 (4.49-4.99) | 1.23 (1.14-1.33) |
Black males | |||||
ACTUR | 58 | 5.17 (3.82-6.84) | 47 | 5.16 (3.74-6.95) | 1.00 (0.65-1.54) |
SEER | 727 | 5.62 (4.96-6.34) | 1,105 | 5.40 (4.82-6.03) | 0.96 (0.81-1.14) |
Lung | |||||
White males | |||||
ACTUR | 130 | 2.35 (1.96-2.79) | 63 | 1.34 (1.02-1.72) | 0.57 (0.41-0.78) |
SEER | 7,137 | 3.83 (3.65-4.02) | 6,672 | 2.70 (2.54-2.86) | 0.70 (0.65-0.76) |
Prostate | |||||
White males | |||||
ACTUR | 112 | 2.07 (1.70-2.49) | 352 | 6.55 (5.87-7.28) | 3.17 (2.55-3.96) |
SEER | 6,877 | 1.25 (1.18-1.31) | 16,704 | 2.63 (2.53-2.72) | 2.11 (1.98-2.25) |
Black males | |||||
ACTUR | 11 | 1.85 (0.89-3.31) | 137 | 15.39 (12.81-18.33) | 8.33 (4.51-17.80) |
SEER | 1,258 | 2.32 (2.07-2.61) | 3,824 | 6.33 (5.95-6.75) | 2.73 (2.39-3.11) |
Testis | |||||
White males | |||||
ACTUR | 634 | 11.18 (10.33-12.09) | 515 | 13.09 (11.98-14.28) | 1.17 (1.04-1.32) |
SEER | 2,937 | 12.57 (12.04-13.12) | 3,327 | 14.05 (13.48-14.64) | 1.12 (1.05-1.19) |
Breast | |||||
White females | |||||
ACTUR | 164 | 33.23 (28.19-38.91) | 190 | 37.31 (32.07-43.13) | 1.12 (0.90-1.40) |
SEER | 27,067 | 30.43 (29.87-31.00) | 35,275 | 30.68 (30.10-31.28) | 1.01 (0.98-1.04) |
Black females | |||||
ACTUR | 76 | 40.54 (26.13-59.75) | 122 | 45.12 (37.38-54.03) | 1.11 (0.74-1.80) |
SEER | 3,448 | 34.96 (33.34-36.63) | 4,862 | 32.32 (30.88-33.81) | 0.92 (0.87-0.99) |
Cervix | |||||
White females | |||||
ACTUR | 43 | 7.29 (5.25-9.88) | 30 | 6.80 (4.57-9.70) | 0.93 (0.56-1.52) |
SEER | 3,254 | 8.67 (8.28-9.07) | 2,830 | 6.94 (6.58-7.30) | 0.80 (0.75-0.86) |
Cancer site . | 1990-1994 . | . | 2000-2004 . | . | IRR* (95% CI†) . |
---|---|---|---|---|---|
. | Count . | Rate† (95% CI) . | Count . | Rate† (95% CI) . | . |
Colorectum | |||||
White males | |||||
ACTUR | 171 | 3.08 (2.63-3.57) | 182 | 4.09 (3.51-4.74) | 1.33 (1.07-1.65) |
SEER | 5,099 | 3.84 (3.64-4.05) | 6,802 | 4.74 (4.49-4.99) | 1.23 (1.14-1.33) |
Black males | |||||
ACTUR | 58 | 5.17 (3.82-6.84) | 47 | 5.16 (3.74-6.95) | 1.00 (0.65-1.54) |
SEER | 727 | 5.62 (4.96-6.34) | 1,105 | 5.40 (4.82-6.03) | 0.96 (0.81-1.14) |
Lung | |||||
White males | |||||
ACTUR | 130 | 2.35 (1.96-2.79) | 63 | 1.34 (1.02-1.72) | 0.57 (0.41-0.78) |
SEER | 7,137 | 3.83 (3.65-4.02) | 6,672 | 2.70 (2.54-2.86) | 0.70 (0.65-0.76) |
Prostate | |||||
White males | |||||
ACTUR | 112 | 2.07 (1.70-2.49) | 352 | 6.55 (5.87-7.28) | 3.17 (2.55-3.96) |
SEER | 6,877 | 1.25 (1.18-1.31) | 16,704 | 2.63 (2.53-2.72) | 2.11 (1.98-2.25) |
Black males | |||||
ACTUR | 11 | 1.85 (0.89-3.31) | 137 | 15.39 (12.81-18.33) | 8.33 (4.51-17.80) |
SEER | 1,258 | 2.32 (2.07-2.61) | 3,824 | 6.33 (5.95-6.75) | 2.73 (2.39-3.11) |
Testis | |||||
White males | |||||
ACTUR | 634 | 11.18 (10.33-12.09) | 515 | 13.09 (11.98-14.28) | 1.17 (1.04-1.32) |
SEER | 2,937 | 12.57 (12.04-13.12) | 3,327 | 14.05 (13.48-14.64) | 1.12 (1.05-1.19) |
Breast | |||||
White females | |||||
ACTUR | 164 | 33.23 (28.19-38.91) | 190 | 37.31 (32.07-43.13) | 1.12 (0.90-1.40) |
SEER | 27,067 | 30.43 (29.87-31.00) | 35,275 | 30.68 (30.10-31.28) | 1.01 (0.98-1.04) |
Black females | |||||
ACTUR | 76 | 40.54 (26.13-59.75) | 122 | 45.12 (37.38-54.03) | 1.11 (0.74-1.80) |
SEER | 3,448 | 34.96 (33.34-36.63) | 4,862 | 32.32 (30.88-33.81) | 0.92 (0.87-0.99) |
Cervix | |||||
White females | |||||
ACTUR | 43 | 7.29 (5.25-9.88) | 30 | 6.80 (4.57-9.70) | 0.93 (0.56-1.52) |
SEER | 3,254 | 8.67 (8.28-9.07) | 2,830 | 6.94 (6.58-7.30) | 0.80 (0.75-0.86) |